Table 1 Clinical characteristics of the LN(+) and LN(−) patients group with colorectal cancer collected from TCGA.
COAD | Lymph node | Total | LN(+) vs. LN(−) p-value | ||
|---|---|---|---|---|---|
Positive | Negative | ||||
Value (%) | Value (%) | Value(%) | |||
179 (45) | 216(55) | 395(100) | |||
Age | mean (SD) | 64.54 ± 13.4 | 68.29 ± 12.37 | 66.58 ± 13 | 0.005 |
median | 66 | 70 | 68 | 0.006 | |
Gender | FEMALE | 89(50) | 90(42) | 179(45) | 0.134 |
MALE | 90(50) | 126(58) | 216(55) | 0.134 | |
NA | 0 | 0 | 0 | ||
Status | Alive | 123(69) | 185(86) | 308(78) | 8.83E-05 |
Dead | 56(31) | 31(14) | 87(22) | 8.83E-05 | |
NA | 0 | 0 | 0 | ||
Race | WHITE | 87(74) | 93(76) | 180(75) | 0.014 |
BLACK OR AFRICAN AMERICAN | 29(25) | 19(16) | 48(20) | 0.014 | |
ASIAN | 1(1) | 10(8) | 11(5) | 0.014 | |
AMERICAN INDIAN OR ALASKA NATIVE | 1(1) | 0(0) | 1(0) | 0.014 | |
NA | 61 | 94 | 155 | ||
Radiation Therapy | NO | 148(97) | 178(98) | 326(98) | 0.549 |
YES | 5(3) | 3(2) | 8(2) | 0.549 | |
NA | 26 | 35 | 0 | ||
Stage | I | 0(0) | 66(31) | 66(17) | 3.30E-79 |
II | 0(0) | 142(66) | 142(36) | 3.30E-79 | |
III | 125(70) | 0(0) | 125(32) | 3.30E-79 | |
IV | 54(30) | 8(4) | 62(16) | 3.30E-79 | |
NA | 0 | 0 | 0 | ||
T stage | t1 | 1(1) | 8(4) | 9(2) | 7.16E-16 |
t2 | 9(5) | 57(26) | 66(17) | 7.16E-16 | |
t3 | 129(72) | 149(69) | 278(70) | 7.16E-16 | |
t4 | 40(22) | 1(0) | 41(10) | 7.16E-16 | |
tis | 0(0) | 0 | 1(0) | 7.16E-16 | |
NA | 0 | 0 | 0 | ||
N stage | n0 | 0(0) | 216(100) | 216(55) | 1.69E-86 |
n1 | 101(56) | 0(0) | 101(26) | 1.69E-86 | |
n2 | 78(44) | 0(0) | 78(20) | 1.69E-86 | |
NA | 0 | 0 | 0 | ||
M stage | m0 | 102(57) | 207(96) | 309(78) | 2.50E-20 |
m1 | 54(30) | 8(4) | 62(16) | 2.50E-20 | |
mx | 23(13) | 0(0) | 23(6) | 2.50E-20 | |
NA | 0 | 1 | 0 | ||
